If this message is not displayed correctly, click here.

No 98, March 2017

Take advantage of the Early Bird registration fees for the 54th ERA-EDTA Congress!

Are you planning to participate in the 54th ERA-EDTA Congress? Do take advantage of the Early Bird registration fees. By registering within March 8, 2017 you can save up to 150 EUR. Get the discount and register now.

Do not miss the 54th ERA-EDTA Congress Late Breaking Clinical Trials abstract submission

 The ERA-EDTA will consider abstracts related to unpublished clinical trials for a special “Late breaking clinical trials” session. The following trials will be considered for evaluation if they comply with the required characteristics:
- a prospective randomised intervention in renal patients (medications, education, dietetics, physiotherapy, etc…), including at least 100 patients;
- a prospective observational study, including at least 500 patients;
- approved by an institutional ethical committee;
- not previously reported or published.
Abstracts may be accepted as oral communications or posters, after regular evaluation by the review committee.
The LBCT abstracts can be submitted through the congress website from March 6 to March 27, 2017.

Just published online! Read the latest NDT articles

Just published online! Read the latest NDT articles

Systematic review shows no advantage for AKI e-alerts
In the systematic review, in which six studies (n = 10 165 patients) were analyzed and which has been published in NDT, e-alerts for AKI did not improve survival or reduce RRT utilization. Even the impact of e-alerts on processes of care was variable. But does it really mean that these devices are obsolete? No! As the authors conclude, additional research is needed to understand those aspects of e-alerts that are most likely to improve care processes and outcomes.

 Read More →

Pendrin – a novel target to treat hypertension?
Pendrin, also known as sodium-independent chloride/iodide transporter, is an antiporter anion exchanger protein that in humans is encoded by the SLC26A4 gene. A new experimental study published in the latest edition of NDT reveals that pendrin might be a key for blood pressure regulation. The study group tested the acute effects of loss of pendrin function and found out that the acute loss of pendrin led to a significant decrease of blood pressure.

 Read More →

A joint review by the CKD-MBD and the ERN Working Groups on the role of phosphate control

High phosphate concentrations are associated with an increased incidence of cardiovascular complications and mortality in the general population and in patients with chronic kidney disease (CKD). As the kidney has a key role in phosphate regulation, phosphate homeostasis is disturbed in patients with kidney disease. CKD-MBD (Chronic Kidney Disease - Mineral and Bone Disorder) and European Renal Nutrition (ERN), both official ERA-EDTA Working Groups, published a joint review on the role of phosphate control. Dr Marc Vervloet, first author of the paper and Vice Chair of the CKD-MBD Working Group, commented its importance: “Among all biomarkers of CKD–MBD, phosphate is most strongly associated with increased mortality".

ERA-EDTA Flash is the official ERA-EDTA eNewsletter

Editor-in-Chief: Mustafa Arici
Editorial Secretariat: Valentina Cocchi
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters
Via XXIV Maggio, 38
43123 Parma - Italy

The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003. If at any time you wish to change personal information that is incorrect or wish to have your personal data deleted, please REPLY this email and specify ‘REMOVE ME FROM YOUR DATABASE’. ERA-EDTA will meet such requests at the earliest possible opportunity by deleting or amending your personal information.